File(s) under permanent embargo
Modulation of interferon activity-associated soluble molecules by appendicitis and appendectomy limits colitis-identification of novel anti-colitic targets
journal contribution
posted on 2023-05-18, 04:34 authored by Cheluvappa, R, Rajaraman Eri, Luo, AS, Grimm, MCThe therapeutic efficacy of interferons (IFNs) in ulcerative colitis is minimal. However, IFN activity-associated molecules have been inadequately investigated. Appendicitis and appendectomy (AA), when done while young, protect against colitis development later. Our novel murine AA model protects against colitis. This therapeutic target-identifying study enumerates IFN activity-associated molecules involved in this protection. Mice with 2 laparotomies were controls (sham-sham/SS). Distal colons were harvested (4 AA-group colons and 4 SS-group colons). Microarray-analysis/reverse transcriptase–polymerase chain reaction-validation was done from RNA from each (3-days/28-days-post-AA). Gene set enrichment analysis (GSEA) software was used to analyze distal colonic gene sets associated with 46 IFN activity-related genes. More AA-upregulated gene sets were associated with IFIT1, IFIT2, IFIT3, IRF7, IFI35, and IFI44 (False Discovery Rate-FDR < 5% and P < 0.001), although only IFIT1, IFIT2, IFIT3, and IFI44 showed individual gene upregulation (P < 0.05). More AA-downregulated gene sets were associated with IRF1, IRF2, IRF4, IRF8, IRF9, IRF2BP1, IFRD1, IFRD2, and IFIH1 (FDR < 5% P < 0.001); although only IRF2BP1 showed individual gene downregulation (P < 0.05). There was significant upregulation (P < 0.05) of IFNZ; and downregulation of IRF2BP2 and IFI30, despite no major associated GSEA differences. IFIT1, IFIT2, IFIT3, and IFI44, with profound AA-induced individual/GSEA upregulation, and their immunomodulatory/ antiproliferative activity, are the best molecules to investigate therapeutic potential. IRF4, IRF8, IRF2BP1, IFRD1, and IFRD2, owing to their profound AA-induced gene set downregulation, and because of their diverse lymphocytic activity, are good targets to competitively inhibit or to treat with exogenous products in knockout animals.
History
Publication title
Journal of Interferon and Cytokine ResearchVolume
35Pagination
108-115ISSN
1079-9907Department/School
School of Health SciencesPublisher
Mary Ann Liebert Inc PublPlace of publication
2 Madison Avenue, Larchmont, USA, Ny, 10538Rights statement
Copyright 2015 Mary Ann Liebert, Inc.Repository Status
- Restricted